$CTS

CTS CORP

Insider trades
1
1
1

No SEC Form 4 filings for $CTS in the last 30 days.

See all $CTS insider activity →

CTS Corporation (CTS) Stock Forecasts

Argus on Aug 12, 2026 lowered its target price for CTS Corp (CTS) to $72.00. The note describes CTS Corp as an electronics manufacturer of sensors, electronic components, and actuators. Other listed items include target or rating changes for APH, IPGP, ESE, AGYS, and LFUS.

Vietnam stock market slips as state-owned stocks retreat after rally

Vietnam’s VN-Index slipped slightly around 1,770 as investors turned cautious amid profit-taking and mixed sector moves. Liquidity eased to 640.8M shares worth VND16.01T on Ho Chi Minh City. GAS led declines, while LPB, MBB, OCB and brokerages like VIX, TCV, CTS gained. State-owned stocks retreated after Monday’s rally.

CTS sentiment & insider activity

Over the past 7 days, alphai's AI scored 3 news stories mentioning CTS (CTS CORP). Coverage has been balanced: 1 bullish, 1 neutral, and 1 bearish.

Recent CTS coverage spans earnings, financial news and market movers.

What's driving CTS

alphai scores every news story that mentions CTS with an AI model for sentiment and relevance, and aggregates insider trades from CTS CORP's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CTS

Score

CTS Corporation (CTS) Stock Forecasts

Argus on Aug 12, 2026 lowered its target price for CTS Corp (CTS) to $72.00. The note describes CTS Corp as an electronics manufacturer of sensors, electronic components, and actuators. Other listed items include target or rating changes for APH, IPGP, ESE, AGYS, and LFUS.

The 5 Most Interesting Analyst Questions From CTS’s Q2 Earnings Call

CTS (CTS) reported Q2 results with management citing growth in medical, industrial, and aerospace/defense, plus operational improvements and a more profitable sales mix. It noted modest transportation declines and one-time items that boosted EPS. Analysts asked about CEO strategy, R&D recurrence, medical margins, pricing and cost inflation, and transportation outlook. CTS shares were about $65.25 after earnings.

$CTSMedAI 8/10

CTS Corporation Q2 2026 Earnings Call Summary

CTS Corporation reported Q2 2026 gross margin of 41.5% and said diversified end markets now make up 59% of revenue. Medical sales grew 45% YoY, industrial rose 16%, while transportation fell 2%. Full-year 2026 sales guidance was raised to $565-$585 million. Management expects aerospace strength in H2 and cautions on tariffs and precious metal inflation.

Leaving Estimates in the Dust: 28 Firms Beating Earnings Expectations

Morgan Stanley research cited by the article says the median S&P 500 EPS surprise was 6% in Q1 2026, above the long-run ~5.5% average. FactSet research cited says firms with positive EPS surprises tend to keep outperforming after results. The article lists 28 companies that beat Wall Street EPS expectations, including Ford (EPS $0.66 vs $0.31), Bloom Energy (EPS $0.78 vs $0.37; revenue >$1B, +164% YoY), and Incyte (EPS $3.09 vs $0.94).

$CTSMedAI 8/10

Why CTS (CTS) Stock Is Up Today

CTS Corporation (NYSE: CTS) shares rose about 5.8% after the company reported Q2 results that beat expectations and raised full-year guidance. CTS said sales were $144.8 million (+7% YoY) and adjusted EPS was $0.74. It now expects 2026 revenue around $575 million (midpoint) and adjusted EPS of $2.63 (midpoint).

Related tickers